CCM
NUVB icon

Connective Capital Management’s Nuvation Bio NUVB Stock Holding History

Connective Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-99,623
Closed -$369K – 74
2025
Q3 		$369K Buy
+99,623
New +$271K 0.34% 43

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Connective Capital Management's NUVB Position: Q4 2025 in Review

Connective Capital Management sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 99,623 shares — an estimated $369K sold.

Connective Capital Management first reported a position in NUVB in Q3 2025 and held it in 1 quarter. The position peaked at $369K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Connective Capital Management reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Connective Capital Management sold 99,623 Nuvation Bio shares in Q4 2025, an estimated $369K.
  • Connective Capital Management first reported a position in Nuvation Bio in Q3 2025 and held it in 1 quarter.
  • Connective Capital Management's Nuvation Bio position peaked at $369K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Connective Capital Management's 13F filing for Q4 2025, filed 19 Feb 2026.